AU3358693A - Peptide fragments of Hsp71 of (M. Tuberculosis) and their use in diagnosis of tuberculosis - Google Patents

Peptide fragments of Hsp71 of (M. Tuberculosis) and their use in diagnosis of tuberculosis

Info

Publication number
AU3358693A
AU3358693A AU33586/93A AU3358693A AU3358693A AU 3358693 A AU3358693 A AU 3358693A AU 33586/93 A AU33586/93 A AU 33586/93A AU 3358693 A AU3358693 A AU 3358693A AU 3358693 A AU3358693 A AU 3358693A
Authority
AU
Australia
Prior art keywords
tuberculosis
hsp71
diagnosis
peptide fragments
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33586/93A
Inventor
Ashraf Elsaghier
Juraj Ivanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU3358693A publication Critical patent/AU3358693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
AU33586/93A 1992-01-17 1993-01-15 Peptide fragments of Hsp71 of (M. Tuberculosis) and their use in diagnosis of tuberculosis Abandoned AU3358693A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929200949A GB9200949D0 (en) 1992-01-17 1992-01-17 Diagnostic peptides
GB9200949 1992-01-17

Publications (1)

Publication Number Publication Date
AU3358693A true AU3358693A (en) 1993-08-03

Family

ID=10708733

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33586/93A Abandoned AU3358693A (en) 1992-01-17 1993-01-15 Peptide fragments of Hsp71 of (M. Tuberculosis) and their use in diagnosis of tuberculosis

Country Status (3)

Country Link
AU (1) AU3358693A (en)
GB (1) GB9200949D0 (en)
WO (1) WO1993014118A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
ES2313719T3 (en) 1993-11-23 2009-03-01 The Regents Of The University Of California ABUNDANT EXTRACELLULAR PRODUCTS AND PROCEDURE OF PRODUCTION AND USE OF THE SAME.
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5750119A (en) 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5837251A (en) * 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
ES2285832T3 (en) 1998-02-20 2007-11-16 Univ Miami ANTIGENIC-PROTEIN PEPTIDE COMPLEX OF MODIFIED THERMAL SHOCK.
US7015309B1 (en) 1999-06-23 2006-03-21 The Wistar Institute Of Anatomy And Biology Pyrrhocoricin-derived peptides, and methods of use thereof
EP1252517A4 (en) * 2000-01-21 2004-10-20 Wistar Inst Biocidal molecules, macromolecular targets and methods of production and use
CA2410903A1 (en) 2000-06-02 2001-12-06 University Of Connecticut Health Center Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
JP4384489B2 (en) 2001-08-20 2009-12-16 ユニバーシティー オブ コネティカット ヘルス センター Method for preparing a composition comprising a heat shock protein or α-2-macroglobulin useful for the treatment of cancer and infectious diseases
US8728170B1 (en) 2006-12-28 2014-05-20 Boston Scientific Scimed, Inc. Bioerodible nano-fibrous and nano-porous conductive composites
DK2257301T3 (en) 2008-03-03 2014-04-28 Univ Miami Immunotherapy based on allogeneic cancer cells.
AU2009226077B2 (en) 2008-03-20 2012-04-19 University Of Miami Heat shock protein gp96 vaccination and methods of using same
KR20170109582A (en) 2015-02-06 2017-09-29 히트 바이오로직스, 인코퍼레이티드 Vector co-expression vaccine and co-stimulatory molecule
CA3040123A1 (en) 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
CA3058938A1 (en) 2017-04-04 2018-10-11 Heat Biologics, Inc. Intratumoral vaccination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0345299A1 (en) * 1987-02-02 1989-12-13 Whitehead Institute For Biomedical Research Mycobacterium tuberculosis genes encoding protein antigens
IE904536A1 (en) * 1989-12-22 1991-07-03 Astra Ab New methods for diagnosis of tuberculosis

Also Published As

Publication number Publication date
WO1993014118A1 (en) 1993-07-22
GB9200949D0 (en) 1992-03-11

Similar Documents

Publication Publication Date Title
AU3358693A (en) Peptide fragments of Hsp71 of (M. Tuberculosis) and their use in diagnosis of tuberculosis
AU4403689A (en) Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
AU2675692A (en) Personal use syringe dispensing and collecting system
AU5671594A (en) Human tissue factor related dna segments, polypeptides and antibodies
AU3450193A (en) 1,5-benzodiazepine derivatives and their use in medicine
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5717496A (en) Composite film and use thereof in the presence of solvents
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU2614888A (en) Soluble human cd4 fragments and uses therefor
AU633294B2 (en) Motilin-like polypeptide and use thereof
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
AU4119397A (en) Novel combination preparations and their use in immunodiagnosis and immunotherapy
AU4762893A (en) Hla-dr3 blocking peptides and their use in the treatment of hla-dr3 associated autoimmune diseases.
AU6761294A (en) Cell surface protein expressed on human cortical thymocyte and their use
AU1405995A (en) Proteases from streptomyces and use thereof in protein expression systems
AU631448B2 (en) Application aid and the use thereof
AU3193089A (en) Prepromotilin and motilin-associated peptide (map)
NZ227594A (en) Human interleukin-1alpha and preparations thereof
AU5704490A (en) Renin-inhibiting peptides, processes for their preparation and their use in medicaments
ZA96239B (en) Novel peptides their preparation and use
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b
AUPN024994A0 (en) Assay and peptides for use therein
AU4588189A (en) Imidazole-containing peptide and preparation thereof